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Fever is an adaptive response to a variety of infectious, inflammatory, and foreign stimuli. The
“febrile response” confers an immunological advantage to the host over invading microorganisms – bacterial, fungal and viral. Fever results from a cytokine-mediated reaction that results in
the generation of acute phase reactants and controlled elevation of core body temperature. The
anterior hypothalamus coordinates the “febrile response” in reaction to the release of endogenous pyrogenes and subsequent up-regulation of prostaglandin synthesis. An ensuing change
in the hypothalamic set point for temperature regulation advances a synchronized physiologic
response from CNS to periphery, on a microscopic and macroscopic level, throughout the entire
human organism. This differs from hyperthermia which refers to heat retention attributable to
unregulated readjustment of the thermoregulatory mechanism. Clinically, an elevation of core
body temperature, whether in fever or hyperthermia, is only the most apparent manifestation
of an intricate mechanism that orchestrates activation of autonomic, immunologic, neurologic,
hematologic, endocrine and behavioral responses.
Fever has been classically described as having three phases.1 In the “initiation phase,” cutaneous
vasoconstriction diverts blood from the body’s surface to its core. Simultaneously, a broad
sympathetic impulse commences rigors (shivering) as opposing muscles groups contract to
contribute to excess heat production. The shunting of blood from epithelium to core organs
and the increase in metabolic activity leads to the elevation of body temperature. In the “plateau
phase,” heat production and heat loss equalize and the body maintains an elevated temperature
through rigors and diaphoresis. In the third phase, or “defervescence,” cutaneous vasodilation
and diaphoresis lead to dissipation and loss of excess heat, thus allowing the body temperature to
drop back to normal.
Hyperthermia occurs when there is disturbances to the central mechanisms of thermoregulation
and heat dissipating mechanisms have been compromised. Although the exact mechanisms are
unknown, “hyperthermia-induced brain injury” has been speculated to cause direct damage to
thermoregulatory centers thus obliterating feedback to the temperature set point elevation.2 Some
have hypothesized that brain injury induces disruption of mesencephalic-diencephalic physiology
responsible for tonic inhibition of thermogenesis and the overriding effects of sympathetic
activation which impair peripheral mechanisms of heat dissipation.3 Contrary to the normal
processes associated with infectious fever, hyperthermia presents as an elevated body temperature
in association with the absence of diaphoresis, tachypnea, and tachycardia.4 Other characteristics
distinguishing hyperthermia from fever include: an inordinately high temperature (greater than
41 C) that may persist for days to weeks, a lack of diurnal variation, a plateau-like pattern of
elevations and maintenance.4 Interestingly, appropriate treatment hinges upon correct diagnosis of
fever versus hyperthermia, as elevated temperature with hyperthermia is lowered more effectively

Medical Subject Headings from the United States National Library of Medicine
Fever

An abnormal elevation of body temperature, usually as a result of
a pathologic process.

Hyperthermia, induced

Abnormally high temperature intentionally induced in living things
regionally or whole body. It is most often induced by radiation
(heat waves, infra-red), ultrasound, or drugs.

Malignant hyperthermia

Rapid and excessive rise of temperature accompanied by
muscular rigidity following general anesthesia
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by external cooling than by antipyretic agents.
Although the causes of this phenomenon
remain speculative, the neurologic effects of
fever with traumatic brain injury, intracerebral
hemorrhage, subarachnoid hemorrhage and
post-operative recovery are significant –
increased temperature has been associated
with increased local cytokine activity, increased
infarct size, increased intracranial pressure,
vasospasm, symptomatic vasospasm, ischemic
brain injury and poor outcomes in the acute
phase of neurologic injury.

Infectious Fever versus
Non-Infectious Fever

In the NICU setting, fevers are classified as
“infectious” or “non-infectious”.5 Clinicians
further characterize them as either “explained”
or “unexplained” according to clinical
findings, laboratory tests, or imaging studies
that elucidate their etiology.6 For example,
pneumonia is an “explained” and “infectious”
cause of fever, confirmed by leukocytosis,
purulent tracheal secretion, positive sputum
cultures and infiltrate on chest radiograph. On
the other hand, atelectasis is an “explained”
but “non-infectious” cause of fever confirmed
by characteristic findings in two or more
lung segments without leukocytosis or
positive sputum cultures. Further still,
central neurogenic fever or post-traumatic
hyperthermia is an “unexplained” and “noninfectious” cause of fever without confirmatory
testing or sufficiently descriptive imaging
studies. Central fever is speculated to result
from damage to hypothalamus, midbrain,
or pons enhanced by increased sympathetic
activity, opening of the ventricles, damage to
the frontal lobes, physical distortion, diffuse
axonal injury, or toxic blood metabolites.8

Implication of Fever, both Infectious
and Non-Infectious, in the NICU

In the critically-ill neurologic or neurosurgical
patient, fever is a double-edged sword, characterized by both beneficial and detrimental
effects on the acutely injured central nervous
system. The beneficial effects include enhanced
resistance to infection, local activation of the
coagulation cascade, cytokine-mediated T-cell
activation, as well as, neutrophil and macrophage recruitment to injured tissues. In the
critically-ill patient, the protective effect of fever
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against the development of infection generally
offset the dangers. Unfortunately, the patient
that has suffered an acute insult to the CNS is
an exception. After the initial injury, secondary brain insults are speculated to be caused
by several processes including mitochondrial
dysfunction, inflammatory response, free radical generation, and excitatory neurotransmitter
release.9 These episodes of secondary brain
injury appear to be caused by or temporally
associated with hypotension, intermittent
hypoxia and ischemia, fever and hyperthermia, cerebral hypertension and elevated intracranial pressure.9
In terms of trauma to the CNS, it is commonly
accepted that elevated temperature exacerbates
secondary brain injury. Fever has been demonstrated to increase glutamate release, provoke
diffuse oxygen free radical production, increase
cytoskeletal protein degradation, and markedly augment the permeability of the bloodbrain barrier.10 Increased permeability allows
activated immune cells to acquire increased
access to the interstitial space. Furthermore,
vasogenic edema leads to increased fluid in
the extracellular space and accumulation of
intracellular fluid resulting in cytotoxic edema.
Despite evidence suggesting that hyperthermia
does not impact the partial pressure of oxygen11
or a causal relationship between elevated brain
temperature and increased intracranial pressure,12 current therapy suggests otherwise.
Fever exacerbates ischemic neuronal damage
and physiologic dysfunction after acute traumatic brain injury, subarachnoid hemorrhage,
and major neurosurgery.13 In addition to the
aforementioned effects, fever also increases
circulating catecholamines boosting cardiovascular output to meet heightened metabolic
demands, further taxing the already damaged
CNS. In sum, the physiologic response to fever
in the CNS has been assumed to contribute
deleterious effects that exceed any potential
benefits of staving off infection.

Relevance to the Neurosurgical Patient

At least half of febrile incidents in the ICU are
of non-infectious origin5 In the neurocritical
and neurosurgical patients the incidence and
prevalence of non-infectious fever are even
greater. Febrile episodes occur in roughly 50%
of patients in the NICU with neurocritical
patients having a slightly lower frequency of
fever, approximately 23%,6 than patients in the
neurosurgical ICU, approximately 47%.14
Fever in the neurocritical and neurosurgical
patient population predominates with vascular
injuries, such as intracerebral hemorrhage and
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subarachnoid hemorrhage. The highest rates of
febrile episode occur in patients with subarachnoid hemorrhage (65%), followed by traumatic
brain injury (40%) and intracranial hemorrhage
(31%); no cause of fever was identified in 28%
of patients, suggesting fever of central origin.6
Fever has been linked to an increase in the
length of stay, subsequent onset of further
febrile episodes. Multiple studies have demonstrated that “non-infectious fever” is common
in both the neurocritical and neurosurgical ICU
patient population. Fever also tends to predominate amongst patients that have suffered either
intracranial injury or traumatic brain injury as
compared to spinal disorders.

Infectious Fever in the NICU

A new fever in an ICU patient can have a
multitude of infectious and non-infectious etiologies. The practice guidelines from the Task
Force of the Society for Critical Care Medicine
(SSCM) and Infectious Disease Society of
America (IDSA) urge for a “careful clinical
assessment” and “cost-conscious approach”
to obtaining a diagnosis through laboratory or
radiological tests.15 The SSCM and IDSA Task
Force recommend perpetual reflection on the
impact of diagnostic testing and radiological
imaging with respect to patient harm, further
nosocomial infection risks, and the likelihood
of legitimate life-sparing intervention. They
argue that “infection be considered regardless
of temperature but that laboratory tests for
infection should be initiated for febrile patients
only if clinical assessment indicates a reasonable
possibility that infection might be present”.15
The common causes of infectious fever in a
NICU patient are the same as those for any
critically ill patient. However, specific considerations should be made for nosocomoial
infections secondary to depressed level of
consciousness and surgical opening of the
cranial vault. In a 2003 article, Commichau
et al.6 reported that fever was associated with
infection in 50% of the 387 patients admitted to
the Columbia University Hospital NICU. In a
European 2002 study, Stochetti et al.10 reported
similar infection rates, again acknowledging
pneumonia as the most frequent infection
in head-injured patients. The most common
infectious causes of fever in the NICU (10–20%
of patients in the ICU) are presented in Table I.
The high incidence of nosocomial infections
(NI) amongst patients admitted to Intensive
Care Units (ICUs) are equally relevant
to patients admitted to Neurocritical and
Neurosurgical ICUs (NICUs). In the neurocritical and neurosurgical patient populations,

nosocomial infection rates also depend on the
severity of illness at presentation (i.e, Grade
of SAH) and the exposure to invasive devices
such as ventilators, central venous catheters
and urinary catheters in addition to neuroscience specific devices, such as ventricular
catheters. In the U.S., nosocomial infection
rates in ICUs are tracked by the “National
Nosocomial Infections Surveillance” System
(NNIS) run by and published annually by
the CDC. Unfortunately, the NNIS does not
collect or analyze data specific to the NICU
setting, thus there is a paucity of data available
on the incidence of NI in the neurocritical or
neurosurgical patient population.
In 1997, Dettenkofer et al.16 began a prospective
study in a ten-bed NICU tracking the incidence
of nosocomial infections over a 30-month study
period. They reported data on 505 patients
with a total of 4,873 patient days and 122 NI
amongst 96 patients (74 patients with one NI,
18 patients with two NI’s, 4 patients with three
NI’s). The overall incidence of NI in the NICU
was 24% (24.2 per 100 patients with a incidence
density of 25.0 per 1,000 patient days), with
nosocomial pneumonia (11.7%) and urinary
tract infections (8.7%) the most frequent cause
of infection, respectively. Interestingly, of the
59 nosocomial pneumonias, only 22 (37%)
were ventilator-associated while 37 (63%)
non-ventilator-associated. Contrary to data on
medical-surgical ICUs, more than half the cases
of nosocomial pneumonia were non-ventilator
associated, which corresponds to decreased
ventilator usage among NICU patients.
Furthermore, the incidence of nosocomial
pneumonias can probably be accounted for by
the known high risk of aspiration pneumonia
for patients with a depressed level of consciousness. With respect to UTI’s, the incidence of
NI’s were strongly associated with device utilization (42 of 44 UTI’s were device-associated).
The incidence of bloodstream infections and
other catheter related infections (local infections) were relatively low when compared to
the incidence of pneumonias and UTI’s (1.4%
and 1.2%, respectively). Finally, the incidence of
ventriculitis and meningitis were also extremely
low (0.8% and 0.4%, respectively) when also
compared to other NI’s.

Non-Infectious Fever in the NICU,
Explained and Unexplained Etiology
The patient with classic protracted fever in the
NICU setting requires a methodical approach.
Given the ramifications, an infectious cause is
always presumed and its etiology sought for
any critically ill patient with new onset of fever
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Table 1

Pneumonia:
Ventilator-Assisted Pneumonia:
occurs in ~ 25% of mechanically ventilated medical-surgical
ICU patients; Pulmonary infections (bronchitis and pneumonia)
accounted for 82% of all infections
and were the predominant cause
of fever in patients with stroke;
Bloodstream Infections:
In absence of IV-line or catheters,
bloodstream infections typically
arise from gastrointestinal and
genitourinary tracts flora.

Intravenous Catheter-Related
Infection:
Stable catheters with good
vascular access are a mainstay
of treatment for the critically-ill.
Infections caused by pathogens
that have colonized an indwelling
vascular device (tunneled, surgically implanted, cuffed central
venous, or subcutaneous central
venous port) can cause localized
or systemic infection

Indication

Work-Up

Notes

leukocytosis, purulent tracheal
secretions, purulent sputum,
decreased breath sounds, rales on
rhonchi, new or worsening infiltrates on chest radiograph

Chest imaging study—chest radio- In cases of co-morbid pleural
graph and/or CT scan (if otherwise effusion, thoracentesis if sufficient
volume or juxtapositioned near
indicated)
lobar consolidation, stain, culture
Cultures of secretions from LRTI
before administration of antibiotic and cytology of pleural fluid
Cultures: Epectorated sputum,
tracheal secretions, broncheoalveolar lavage

Any new patient with fever; even
when clinical findings do not
strongly suggest a non-infectious
cause, because positive culture
has important prognostic and
therapeutic implications

No more than three blood samples
(10-15 ml each) for culture need to
be drawn during the first 24 hours
after fever onset, and two blood
samples should generally suffice;
draw at least two blood samples
from separate venipuncture sites
at least ten minutes apart using
proper sterile techniques

Difficulty drawing or infusing
through the catheter site, inflammation at the insertion site;
Recovery of microorganisms
from the blood at multiple blood
cultures; Rapid onset of infection
associated with fulminant shock;
Multiple positive blood cultures

Again, no more than three blood
samples (10-15 ml each) for
culture need to be drawn during
the first 24 hours after fever onset,
and two blood samples should
generally suffice; draw at least
two blood samples from separate
venipuncture sites at least ten
minutes apart using proper sterile
techniques; infection at the insertion
site as evidence by inflammation
or purulence at the exit site or an
intravascular site (cultures and
thrombosis)

Sinusitis:

Cough and leukocytosis with
purulent nasal discharge, maxillary
Occurs in 5% of ICU patients, but
facial tenderness, periorbital
with increased frequency in neuroedema, headache, tooth pain,
surgical patients secondary to
earache, sorethroat, foul breath,
chronic intubation and NG tubes
wheezing

Remove nasotracheal or nasogastric Risk factors include facial
tube placement, nasal packing, CT fractures, steroid administration,
scan, coronal radiographs, or MRI, NG/NT tubes, neurosurgery
puncture and aspiration of sinuses
under sterile conditions, gram stain
and culture of organisms

Nosocomial Diarrhea:

Remove offending AB agent; diag- Diarrhea is caused by enteral
nosis via “Gold Standard” is tissue feeding, antibiotic overuse or
culture from stool sample; Elisa
infectious causes
Immunoassay test for toxins, Rapid
C-Diff Test, gram stain and culture
of organisms

Most common febrile diarrhea
in the ICU is Clostridium difficile;
Antibiotic administration associated diarrhea (check medical
record for previous use of
Clindamycin or Cephalosporin or
Fluoroquinolones)

2+ stools per day that conform to
the container
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Table 1 continued
Indication

Work-Up

Pyuria, leukocytosis, purulent
discharge from urethral meatus,
obstructive symptoms, retention
symptoms, suprapubic tenderness,
costovertebral angle tenderness,
change in mental status, fluid
retention, edema, headache,
change in mental status

Urine Culture (clean catch or urine
port), remove pre-existing Foley
catheter, gram stain or urinary
sediment, and culture of organisms

Surgical Site Infections

purulent discharge, tenderness,
dehiscence, erythema, purulence,
or tenderness

Examine surgical wound; Remove
drains or packing, open the
wound, aspirate under sterile
conditions, irrigate; Gram stain and
culture of organisms from pus or
material deep within the wound site

CNS Infection

Leukocytosis and alterations in
neurological parameters, change
in mental status, focal findings,
absence of neurological findings,
lateral shift of midline structures
on imaging study, loss of suprachiasmatic and basilar cisterns,
obliteration of the fourth ventricle

CT scan or MRI; Lumbar Puncture,
determination of glucose, protein
and LDH, Gram stain, white cell
count and culture of CSF

Urinary Tract Infections:
Urinary tract disease in the
presence of bladder catheters,
obstruction of the urethra, bladder
or ureters, leukocyte esterase
dipstick test

in NICU. However, there are equally legitimate
noninfectious causes that must be considered
as well.
Avoidance of fever and hyperthermia remains
a major aim in the management of patients in
the NICU. However, this goal is not commonly
achieved given the uncertain etiology of a
potentially infectious or non-infectious fever.
A fundamental principle in this setting is that
the management of a classic fever of unknown
origin is that “therapy should be withheld,
whenever possible, until the cause of fever has
been determined, so that it can be tailored to a
specific diagnosis”.7
Within the non-infectious etiologies, there
are four subcategories of non-Infectious fever
which are the following:
1. Non-Infectious Inflammatory Disease:
Autoimmune Diseases, Rheumatologic
Phenomenon,
2. Neoplastic Disease:
Primary CNS Tumors and Malignancies,
Leukemias and Lymphomas, Metastatic
Disease, Oncologic Diseases
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3. Pharmacologic Causes:
Drug Fever, Withdrawal Syndromes,
Neuroleptic Malignant Syndrome,
Malignant Hyperthermia, Chemical
Meningitis, Drug Toxicities
4. Post-Traumatic or Peri-Operative:
Central Fever, Neurogenic Fever, Aseptic
Meningitis, Atelectasis or ARDS without
Pneumonia, Deep Venous Thrombosis,
Posterior Fossa Syndrome
Fever is typical in a variety of acute and chronic
neurological disorders confronted in the neurocritical and neurosurgical patient population. Copious experimental evidence suggests
that fever is associated with neuronal injury in
conditions such as cerebral ischemia, subarachnoid hemorrhage, intracerebal hemorrhage,
peri-operative neurosurgical recovery and
traumatic brain injury. However, conclusive
evidence linking control of non-infectious fever
to improved outcomes has inherent difficulties
because central neurogenic fever and posttraumatic hyperthermia are diagnoses of exclusion demanding a thorough previous infectious
work-up. The impact of fever control in the

Notes

Takes a high index of suspicion

NICU is at the mercy of a veteran clinician with
a high index of suspicion because traditional
methods of fever control are ineffective.

Treatment Dilemma: “To treat or not
to treat”

In NICU patients with fever, the clinical sign of
pneumonia, bacteremia, sinusitis, UTI, or meningitis or ventriculitis should direct the therapy
and choice of an appropriate antibiotic relatively immediately. First, all cultures should be
obtained, while all central lines placed for >48
hours and the nasal tube should be removed
and cultured using semiquantitative or quantitative cultures. If fever persists for 48–96
hours after antibiotic treatment and without
the cause or source of the infection being
identified, the patient should be reevaluated
for risk factors associated with fungal infection
(initiation of empiric antifungal treatment is
indicated), while additional diagnostic test,
including venography, CBC with differential
and eosinophil count, and abdominal imaging
are indicated.
During recent years, several biomarkers have
been proposed as adjunctive markers for the
evaluation of fever, aiming to discriminate
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between an infectious cause from a noninfectious reaction or clandestine inflammatory diseases. The biomarkers include: serum
procalcitonin assays with variable cutoffs,
endotoxin detection systems, triggering receptor expressed on myeloid cells-S (TREM-1),
C-reactive protein (CRP), tumor necrosis
factor-α, and interleukin-6. From all the above
biomarkers, serum procalcitonin assay is
approved for early detection of bacterial infection/sepsis during the first day of ICU admission, while the rest have yet to be validated.
The treatment of neurocritical or neurosurgical
patients with central neurogenic fever hinges
upon the axiomatic decision to declare a fever
to be of infectious or non-infectious cause. For
instance, to operate on the presumption that a
patient has an infection until proven otherwise
demands the utilization of rigorous empiric
antibiotics regimens. The use of these medications is far from benign. In the ICU setting
with all its innate risk factors for nosocomial
infections, empiric antibiotic utilization can
lead the patient to be unnecessarily exposed to
courses of antibiotics with inherent toxicities,
drug interactions and side effects that are conceivably detrimental to recovery or elucidation
of the fevers origin. Furthermore, a response
to antibiotics is an unreliable criterion for
diagnosing or excluding bacterial or viral CNS
infection, especially in the context of neurocritical or neurosurgical patients with intrinsic
risks for non-infectious fever anyway.

Conclusion: Treatment Implications of
Infectious versus Non-Infectious Fever

Clinical signs of fever are frequent in neurocritical and neurosurgical patients, and
antibiotics are often administered without
proof of infection. The clinical characteristics
of patients with infectious fever and non-
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infectious fever markedly overlap. Classical
markers of infection cannot differentiate
reliably between inflammation and infection
after neurosurgery.17 The neurosurgical patient
having suffered a CNS insult but lacking a
documented source of fever, has a central
neurogenic fever or post-traumatic hyperthermia by definition. To make the diagnosis
of non-infectious unexplained fever (central
neurogenic fever or post-traumatic hyperthermia) the clinician must have a high index of
suspicion. On the NICU, the clinician combats
inherent limitations of the physical exam and
neurological exam, while racing against the
incubation period for cultures, and exponential growth curve of infectious organisms in
vivo. The critical sequelae of either untreated
infections or unmanaged central neurogenic
fever are urgent dilemmas in the neurocritical and neurosurgical intensive care setting.
Regardless, the adverse effects of temperature
elevation on neurological recovery are clear.
The maxim that “time is tissue” and now
“temp is tissue” demands further investigation
and further trials of antipyretic medications,
anti-hyperthermia strategies such as intravascular cooling techniques in addition to surgical interventions for tissue sparing before the
onset of further ischemic damage or coagulative necrosis in the CNS.

4. Childers MK, Upright J and Smith DW. (1994). Posttraumatic hyperthermia induced brain injury rehabilitation.
Brain Injury, 8(4), 335–343.
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